Cargando…
HDAC4 Inhibitors as Antivascular Senescence Therapeutics
Aging is an inevitable consequence of life, and during this process, the epigenetic landscape changes and reactive oxygen species (ROS) accumulation increases. Inevitably, these changes are common in many age-related diseases, including neurodegeneration, hypertension, and cardiovascular diseases. I...
Autores principales: | Huang, Chuoji, Lin, Zhongxiao, Liu, Xiaoyan, Ding, Qian, Cai, Jianghong, Zhang, Zhongyi, Rose, Peter, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259336/ https://www.ncbi.nlm.nih.gov/pubmed/35814270 http://dx.doi.org/10.1155/2022/3087916 |
Ejemplares similares
-
Discovery of deoxyandrographolide and its novel effect on vascular senescence by targeting HDAC1
por: Lin, Zhongxiao, et al.
Publicado: (2023) -
Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020) -
Targeting Epigenetic Mechanisms in Vascular Aging
por: Lin, Zhongxiao, et al.
Publicado: (2022) -
Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010) -
New insights of epigenetics in vascular and cellular senescence
por: Zhu, Menglin, et al.
Publicado: (2021)